How were (MSLI)'s earnings last quarter?

(MSLI) (NASDAQ:MSLI) issued its quarterly earnings data on Monday, August, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.03. The company earned $7.73 million during the quarter, compared to analyst estimates of $17.19 million.

What other stocks do shareholders of (MSLI) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (MSLI) investors own include ProMetic Life Sciences (PLI) , Palatin Technologies (PTN) , Anavex Life Sciences (AVXL) , Biocept (BIOC) , Cancer Genetics (CGIX) , InterCloud Systems (ICLD) , Merus Labs International (MSL) , AllianceBernstein (AB) and Acorn Energy (ACFN) .

NASDAQ:MSLI

(MSLI) (MSLI) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free MSLI Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $1.30
▼
$1.30
50-Day Range: N/A
52-Week Range: $0.70
▼
$1.33

Volume: N/A
Average Volume: 56,140 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (MSLI) alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About (MSLI) Stock (NASDAQ:MSLI)

Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MSLI Stock News Headlines

January 28, 2024 | msn.com

Medico-Legal Society Of India Writes To PM Modi Raising Concerns Regarding Latest ICU Guidelines

January 12, 2024 | msn.com

How did Lynn Yamada Davis die? Popular social media star and the face of Cooking with Lynja was 67

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

January 12, 2024 | msn.com

John Webb obituary: Former Brands Hatch circuit boss dies aged 92

January 12, 2024 | msn.com

BlackRock, world's largest asset manager, pays $12.5 bln for Global Infrastructure Partners

January 4, 2024 | msn.com

Man recovering after stabbing, suspect arrested

October 28, 2023 | msn.com

'Inadequate Infrastructure Main Reason For Death Of Critical Patients' MSLI Survey

April 12, 2023 | msn.com

Disneyland announces closing date for Splash Mountain

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 12, 2023 | msn.com

Glastonbury resale dates confirmed with six tips to secure a ticket

March 8, 2023 | msn.com

Kentucky man sentenced to 18 years for trafficking fentanyl into Virginia

March 8, 2023 | msn.com

Wake Up With Perfect Hair Every Morning and Extend Your Blowout When You Use Sleepy Tie

February 23, 2023 | msn.com

"You Ain't No Youngin": LeBron James Jokes With Damian Lillard About Getting Older In NBA

February 11, 2023 | msn.com

NDMA dispatches 16.5 tons relief shipment to Turkiye

February 11, 2023 | msn.com

New-look Blues look to get back on track, host Coyotes

January 15, 2023 | msn.com

As possible recession looms, these fields have best job security: report

December 29, 2022 | msn.com

Mohammed Ben Sulayem opens up on the ‘complexity’ of FIA presidential role

December 29, 2022 | msn.com

Boston high school basketball player punches ref in face: Police

November 21, 2022 | msn.com

Mangaluru autorickshaw blast ‘inspired by global terror groups’: Police

May 9, 2022 | wsj.com

Pulitzer Board Commends Journalists of Ukraine for War Coverage

See More Headlines

Receive MSLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (MSLI) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/10/2015
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:MSLI
CUSIP: N/A
CIK: 1031516
Web: www.meruslabs.com
Phone: +1-905-7260995
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Michael S. Cloutier
Independent Chairman of the Board
Bio & Compensation -
Barry Fishman
Chief Executive Officer, Director
Bio & Compensation -
Michael Scott Bumby
Chief Financial Officer
Robert McLay
Vice President - Sales and Marketing
Bio & Compensation -
Frank Rotmann
Vice President and Head of European Operations
Bio & Compensation -
Robert Bloch M.D.
Director
Bio & Compensation -
Theresa Sheila Firestone
Independent Director
Bio & Compensation -
David D. Guebert CPA
Independent Director
Bio & Compensation -
Robert S. Pollock
Independent Director
Bio & Compensation -
Timothy G. Sorensen
Independent Director
Bio & Compensation -

MSLI Stock Analysis - Frequently Asked Questions

How were (MSLI)'s earnings last quarter?: (MSLI) (NASDAQ:MSLI) issued its quarterly earnings data on Monday, August, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.03. The company earned $7.73 million during the quarter, compared to analyst estimates of $17.19 million.
What other stocks do shareholders of (MSLI) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (MSLI) investors own include ProMetic Life Sciences (PLI), Palatin Technologies (PTN), Anavex Life Sciences (AVXL), Biocept (BIOC), Cancer Genetics (CGIX), InterCloud Systems (ICLD), Merus Labs International (MSL), AllianceBernstein (AB) and Acorn Energy (ACFN).

This page (NASDAQ:MSLI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(MSLI) (MSLI) Stock Price, News & Analysis

About (MSLI) Stock (NASDAQ:MSLI)

MSLI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

MSLI Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info